Abstract. Sepsis syndrome and septic shock remain significant causes of morbidity and mortality. To date, clinical trials of novel agents to treat sepsis have failed to demonstrate clinical efficacy despite considerable animal data to suggest a positive therapeutic benefit. This article reviews the recent major clinical trials on sepsis and discusses the hypotheses on which these therapies are based and the critical issues associated with clinical sepsis. Recommendations for future clinical trials on sepsis are made.
Article PDF
Similar content being viewed by others
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fisher, Jr., C., Zheng, Y. Potential Strategies for Inflammatory Mediator Manipulation: Retrospect and Prospect. World J. Surg. 20, 447–453 (1996). https://doi.org/10.1007/s002689900070
Issue Date:
DOI: https://doi.org/10.1007/s002689900070